Rocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results
Rocky Mountain Chocolate Factory reported fiscal 2026 results, showing revenue decline to $27.5 M from $29.6 M and a net loss of $4.6 M, an improvement from the prior year’s $6.1 M loss. Fourth‑quarter revenue dropped 24% to $6.8 M, with product‑mix challenges hurting packaged sales. The company reduced operating expenses by $4.4 M year‑over‑year, narrowing the EBITDA gap to –$2.1 M from –$4.7 M. Management highlighted progress in margin improvement, production efficiency, and franchise development as foundations for future growth.
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
NurExone Biologic reported Q1 2026 results, posting a US$1.77 million net loss while keeping R&D spend steady at US$0.63 million. The company closed a non‑brokered private placement of 1.3 million units, raising roughly US$642 k, and announced a batch‑to‑batch consistency validation that readies its exosome...
SAIC Announces First Quarter of Fiscal Year 2027 Results
Science Applications International Corp (SAIC) reported first‑quarter fiscal 2027 revenue of $1.91 billion, a modest 2% increase year‑over‑year, driven partly by the recent SilverEdge acquisition. Adjusted EBITDA margin expanded to 11.6% and net income jumped 69% to $115 million, resulting in adjusted...
Patagonia Gold Quarter 1 2026 Financial Results
Patagonia Gold Corp. reported its Q1 2026 results, highlighting the start of leaching at the Calcatreu project in Argentina and modest production from its Cap‑Oeste operation. The company generated 390 gold‑equivalent ounces and sold 432 ounces, delivering US$2.1 million in revenue. Exploration...
Canals Raises $35M to Eliminate Friction From the Industrial Supply Chain
Canals announced a $35 million financing round led by Base10 Partners to accelerate its AI platform for wholesale distribution. The company, already serving over 100 distributors, has processed more than 8 million sales orders and $5 billion in payables. Customers report doubled quote‑conversion...
Seanergy Maritime Reports First Quarter 2026 Financial Results
Seanergy Maritime Holdings posted a strong Q1 2026, reporting net income of $9.7 million and adjusted EBITDA of $28.1 million, a 251% year‑over‑year increase. The company declared a $0.20 per‑share cash dividend, marking its 18th consecutive quarterly payout. It expanded its fleet...
Toro Corp. Reports Net Income of $0.5 Million for the Three Months Ended March 31, 2026
Toro Corp. reported first‑quarter 2026 vessel revenues of $6.0 million, up 9.1% year‑over‑year, while net income fell to $0.5 million, a 68% decline that turned earnings per share negative at $(0.023). EBITDA improved to $1.3 million and cash slipped to $81.6 million after a...
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
Conavi Medical Corp. secured FDA 510(k) clearance for its next‑generation Novasight™ Hybrid intravascular imaging system, integrating IVUS and OCT into a single workflow. The company also earned the 2026 MedTech Breakthrough and TAG Innovation awards, underscoring the technology’s clinical promise....
West Red Lake Gold Reports Q1 2026 Financial Results and Operations Summary
West Red Lake Gold Mines Ltd. posted Q1 2026 results as it ramps up post‑commercial production at its Madsen Mine in Ontario’s Red Lake district. The company produced 5,667 ounces of gold and sold 6,165 ounces at an average realized...
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Kailera Therapeutics reported Q1 2026 results, highlighting major clinical progress across its obesity pipeline and a successful $718.8 million IPO. The company launched a global Phase 3 KaiNETIC program for ribupatide injection, reported strong Phase 2 oral ribupatide weight‑loss data, and disclosed positive...
ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones
ONWARD Medical reported Q1 2026 results, delivering 70 ARC‑EX systems and expanding availability to over 100 clinics across the US and Europe. The company launched the Empower BP pivotal study, enrolling its first participant and activating 12 sites to evaluate the ARC‑IM...
LexinFintech Holdings Ltd. Reports First Quarter 2026 Unaudited Financial Results
LexinFintech Holdings Ltd. posted its Q1 2026 unaudited results, reporting loan originations of RMB 57.9 bn (≈$8.4 bn), up 15.9% quarter‑over‑quarter. Total operating revenue rose 6.6% year‑over‑year to RMB 3.3 bn (≈$480 m), while net income fell 53% YoY to RMB 201 m (≈$29 m). Non‑consumer finance lines, especially the...
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data From Study 108, a Phase 2a/2b Open-Label Extension...
Abivax reported Q1 2026 results, highlighting €491.6 million (≈$540 million) in cash and a runway extending into Q4 2027. The company released three‑year interim data from Study 108, showing that 68% of 130 ulcerative colitis patients remained in clinical remission after 144 weeks of obefazimod...
Pro Kapital Council Approved Consolidated Interim Report for I Quarter and 3 Months of 2026 (Unaudited)
Pro Kapital Council reported Q1 2026 revenue of €15.1 million (≈$16.6 million), a 21% increase year‑over‑year, driven by apartment handovers in Tallinn, Riga and Vilnius. Gross profit rose to €5.7 million and operating profit to €4.0 million, while net profit reached €2.8 million (≈$3.1 million). Cash generated...
EnWave Reports 2026 Second Quarter Consolidated Interim Financial Results
EnWave Corp reported a sharp drop in Q2 2026 revenue, down 69% year‑over‑year to CAD 1.16 million (≈US $860 k). While gross margin improved to 35% thanks to lower fabrication costs, the company posted an adjusted EBITDA loss of CAD 775 k (≈US $570 k), widening from a modest...